Company Registration No. 15878502 (England and Wales)
INNOVARUS LTD
Annual Report and Statement of Accounts
For the Period from 05 August 2024 to 31 August 2025

INNOVARUS LTD

Annual report and statement of accounts for the period ending 31/08/2025

INNOVARUS LTD

Financial statement for the period ended 31/08/2025

Company Information

1 Statutory Information
Company Number 15878502
Registered Office NO.19S6 OPEN ACCESS LAB MERESIDE C/O LOGISTICS NO. 21
ALDERLEY PARK
SK10 4TG
2 Directors
Directors who held office during the period were:
Saeid BAZRAEI   
Amin FATHI   
Iman FATHI   
JAFARI NODOUSHAN, Milad, Dr Resigned   11/08/2024
3 Principal Activity
Pharmaceutical research and development, specialising in long-acting injectable drug delivery systems.
4 Employees
Average number of employees, including directors, during the year was as follows:
2025 4

INNOVARUS LTD

Financial statement for the period ended 31/08/2025

Statement of Financial Position

2025
£
Fixed Assets -
Current Assets 211,048
Creditors: amounts falling due within one year (93,507)
Net Current Assets 117,541
Total assets less current liabilities 117,541
Creditors: amounts falling due after one year (222,405)
Net Assets (104,864)
Capital and reserves (104,864)
For the period ending 31/08/2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Approved by the Board on 31 July 2026
Amin Fathi
Company Registration No. 15878502